Hepatitis C Virus (HCV) Antiviral Market

Hepatitis C Virus (HCV) Antiviral Market: Global Industry Analysis and Forecast to 2020

Hepatitis C Virus (HCV) Antiviral Market Segmented By types, application, products, technology

Market Overview

Inflammation of liver causes hepatitis. Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection.

Chronic hepatitis C is diagnosed by liver biopsy and blood tests. According to World Health Organization (WHO), globally 130 million to 150 million people are suffering from chronic hepatitis C. Hepatitis C is treated with antiviral drugs to inhibit the growth of virus and prevent liver damage. According to World Health Organization (WHO), 50% to 90% of people suffering from hepatitis C are treated with antiviral treatment.

North America dominates the global market for hepatitis C virus antiviral due to rising incidence of infectious diseases. Asia followed by the Europe are expected to show high growth rates in the next five years in global hepatitis C virus antiviral market.

China and India are expected to be the fastest growing hepatitis C virus antiviral markets in Asia-Pacific region. Some of the key driving forces for hepatitis C virus antiviral market in emerging countries are large pool of patients, increasing awareness programs and rising government funding.

In recent times there is increased use of hepatitis C virus antiviral due to increasing incidence of chronic infection with hepatitis C virus. Increase in healthcare expenditure, changing lifestyle and increasing government initiatives are some of the key factors driving the growth for global hepatitis C virus antiviral market.

In addition, increasing healthcare awareness is also fuelling the growth of global hepatitis C virus antiviral market. However, stringent regulation for approval of hepatitis C antiviral is the major factors restraining the growth for the global hepatitis C virus antiviral market.

Introduction of interferon-free oral therapies would develop opportunity for the global hepatitis C virus antiviral market. The trend for global hepatitis C virus antiviral market is rise in awareness programs and promoting partnerships by World Health Organization (WHO). Some of the major companies operating in the global hepatitis C virus antiviral market are Merck & Co., Genentech, Merck, Vertex, Janssen and Medivir AB, F. Hoffmann-La Roche,  Bristol Myers Squibb, AbbVie and Gilead Sciences.

Find Out More about the Report Coverage

Key points covered in the report

  • Report segments the market on the basis of types, application, products, technology, etc (as applicable)
  • The report covers geographic segmentation

    • North America
    • Europe
    • Asia
    • RoW
  • The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020
  • The report provides company profiles of some of the leading companies operating in the market
  • The report also provides porters five forces analysis of the market.

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Recommendations

Molecular Diagnostics Reagent Market

Rising prevalence and incidences of diseases is the prime driver for the Molecular Diagnostic Reagent market. Molecular Diagnostic Reagents are used to monitor the therapeutic efficacy of drugs. .

Trichomonas Rapid Testing Market

Doctors recommend the use of trichomonas rapid testing kits for pregnant women. The increased risk of HIV is propelling the trichomonas rapid testing market..

Treponema Pallidum Tests Market

Treponema Pallidum Tests Market is expected to account for over US$ 225 Mn, in terms of value, With a CAGR of 5.7% through 2026. .

Adult Hemoglobinopathy Testing Market

The global adult hemoglobinopathy testing market is projected to grow at a CAGR of 3.9% throughout the forecast period, Favorable reimbursement for adult hemoglobinopathy testing is expected to drive the growth of the adult hemoglobinopathy testing market over the forecast period..

Our Clients

Our Clients